about
Protandim, a fundamentally new antioxidant approach in chemoprevention using mouse two-stage skin carcinogenesis as a modelThe Role of PPARgamma Receptors and Leukotriene B(4) Receptors in Mediating the Effects of LY293111 in Pancreatic CancerInflammation and cancerLipoxygenase and cyclooxygenase metabolism: new insights in treatment and chemoprevention of pancreatic cancerCancer, inflammation and the AT1 and AT2 receptorsHepatocyte Growth Factor from a Clinical Perspective: A Pancreatic Cancer ChallengeAnti-inflammatory/antioxidant use in long-term maintenance cancer therapy: a new therapeutic approach to disease progression and recurrenceChronic Pancreatitis and Pancreatic CancerInflammation-induced cell proliferation potentiates DNA damage-induced mutations in vivoPancreatic cancer: associations of inflammatory potential of diet, cigarette smoking and long-standing diabetesInflammatory mechanisms contributing to pancreatic cancer development.Evidence of Notch pathway activation in the ectatic ducts of chronic pancreatitis.Nuclear factor (erythroid-derived 2)-like 2 regulates drug resistance in pancreatic cancer cells.Comparative characterization of stroma cells and ductal epithelium in chronic pancreatitis and pancreatic ductal adenocarcinoma.NADPH oxidases: a perspective on reactive oxygen species production in tumor biologyComparative analysis of clinicopathological correlations of cyclooxygenase-2 expression in resectable pancreatic cancerOverexpression of c-met in the early stage of pancreatic carcinogenesis; altered expression is not sufficient for progression from chronic pancreatitis to pancreatic cancerMast cells in tumor microenvironment promotes the in vivo growth of pancreatic ductal adenocarcinoma.A prospective study of magnesium and iron intake and pancreatic cancer in men.Mucin glycosylation is altered by pro-inflammatory signaling in pancreatic-cancer cells.Constitutive non-canonical NFkappaB signaling in pancreatic cancer cellsSynthesis and evaluation of macrocyclic diarylether heptanoid natural products and their analogsComplex role for the immune system in initiation and progression of pancreatic cancer.Up-regulation and sustained activation of Stat1 are essential for interferon-gamma (IFN-gamma)-induced dual oxidase 2 (Duox2) and dual oxidase A2 (DuoxA2) expression in human pancreatic cancer cell lines.Short-term Intervention to Revert Premalignant Lesions as Strategy to Prevent Gastrointestinal Cancers.Tumor-associated macrophages exhibit pro- and anti-inflammatory properties by which they impact on pancreatic tumorigenesis.Ectoenzymes and cholinesterase activity and biomarkers of oxidative stress in patients with lung cancer.Driver mutations: a roadmap for getting close and personal in pancreatic cancerRisk factors for pancreatic cancer: case-control studyPharmacokinetics, protein binding and metabolism of a quinoxaline urea analog as an NF-κB inhibitor in mice and rats by LC-MS/MS.Advances in diagnosis, treatment and palliation of pancreatic carcinoma: 1990-2010.Discovering the route from inflammation to pancreatic cancer.Independent and joint effect of type 2 diabetes and gastric and hepatobiliary diseases on risk of pancreatic cancer risk: 10-year follow-up of population-based cohort.Pancreatitis and pancreatic cancer in two large pooled case-control studies.Digitoflavone inhibits IκBα kinase and enhances apoptosis induced by TNFα through downregulation of expression of nuclear factor κB-regulated gene products in human pancreatic cancer cells.Change of fucosylated IgG2 Fc-glycoforms in pancreatitis and pancreatic adenocarcinoma: a promising disease-classification model.Molecular biology of pancreatic cancer.SCF(beta-TrCP1) controls Smad4 protein stability in pancreatic cancer cellsMacrophage polarization in pancreatic carcinoma: role of heparanase enzyme.Targeting IL-17B-IL-17RB signaling with an anti-IL-17RB antibody blocks pancreatic cancer metastasis by silencing multiple chemokines.
P2860
Q21143797-5C4C6BC4-21D8-47A1-84D1-C1CA1F8B3283Q21342813-243A21E3-3D75-44A4-A8EC-1F0828A10526Q24649640-722CB353-EBC7-4244-82B3-A9B284F4F81FQ24800010-E0F3FF6A-AE0F-405B-9A7F-1FAF86253A5EQ24806378-B823B8A7-C141-41C9-9D97-98B465490F9EQ26781273-ED1E1A8F-A3D2-4DC2-A982-8AA099F42557Q27010314-D7035B68-495E-42CF-AF5E-FF940719EFAFQ27025915-4311CD69-E4CE-4A5A-9E4B-06FD226E4D7EQ27311572-FE260151-BB11-414D-B5D2-506E09B498B7Q28392875-2DBA75A9-7AB8-481A-AEC9-A630D7F8B442Q31067795-AE8545EC-B378-4C17-A17A-CF7AFE013DABQ33309441-887770B4-ADDF-4D74-96F2-A959964AF528Q33527780-D72791B7-0B1E-41D6-AEC9-787B0B9E4012Q33567742-9BD45036-5AC5-418E-BF93-0B55B78103C5Q33632660-B92F97A3-27FD-44B2-A93C-89C613B870D8Q33798878-4AA01C00-A725-4F2D-A442-C81572AB4092Q33868282-03817F75-1BAC-498E-94EF-7A0FA355B802Q33872716-1BCD3676-36BA-4167-94E8-DC3C53FF395BQ33883574-2854D332-9EA2-412D-B448-28732847331DQ33945484-103C3310-B5DD-4C4A-A327-C66C6F2EAAE6Q34021737-8A5F33EC-98CD-4E42-A99C-C8B1C139072FQ34089945-1877EA87-0D7D-4440-953E-039B948360DDQ34093784-1C055F42-DFA0-49E6-B815-52A59937AD2BQ34164583-16BD028B-97F6-4AEB-BE8D-0FD1BF74AB54Q34305282-D14778BC-CD45-47F7-B730-34D1250D6E5DQ34399827-80688458-2D2F-4335-9734-38B0CA58B3C2Q34488094-1635871E-1412-4B81-9E8D-F4A226E32443Q34582122-468BF366-D651-40BD-BFBA-AC4EB230AE11Q34582332-4A74B5B3-6F92-41AC-944A-0036BB84005CQ34618117-15C4588E-7171-4D72-8C2E-572F4AC68C95Q34635042-FCB44423-FBA0-4027-B8DD-49C4F63A8495Q34645978-E0B25482-2DAC-4CD5-861C-2AA5A251BA16Q34658322-5B5B90EE-CDED-4327-871A-FFD1B17CFD0BQ35003467-5E186E7A-AFE9-471E-9EC4-D738A89750DEQ35023062-D0CFB161-750B-4AE0-8699-150B1ACA088BQ35031719-817375AD-2D28-4829-8AA1-1CF27CB573C8Q35085975-5ABDDD3D-9B54-448D-9C8E-310BDAB422EAQ35087762-AF4D78B5-7E4B-49E1-B48A-A687A6F77A32Q35102577-D4299D9F-6ACC-4706-96A0-6E3E8162E1E9Q35161476-29C1D7B5-FFEA-4C44-AEC8-3C3A9920430B
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Inflammation and the development of pancreatic cancer.
@ast
Inflammation and the development of pancreatic cancer.
@en
Inflammation and the development of pancreatic cancer.
@nl
type
label
Inflammation and the development of pancreatic cancer.
@ast
Inflammation and the development of pancreatic cancer.
@en
Inflammation and the development of pancreatic cancer.
@nl
prefLabel
Inflammation and the development of pancreatic cancer.
@ast
Inflammation and the development of pancreatic cancer.
@en
Inflammation and the development of pancreatic cancer.
@nl
P1433
P1476
Inflammation and the development of pancreatic cancer.
@en
P2093
B Mark Evers
Buckminster Farrow
P304
P356
10.1016/S0960-7404(02)00015-4
P577
2002-05-01T00:00:00Z